Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.

Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a hydrophilic side-chain macromer for glistening resistance.

Abstract: An ocular implant alters iris color for medical and cosmetic purposes and is made of an inert, nontoxic, foldable and preferably permeable to fluid flow material. It is an annular non-planar structure that fits over the iris yet leaves the natural lens uncovered and extends approximately to the iridocorneal angle. Two different kinds of arc sections of a non-uniform thickness make up the structure: passage arc sections and support arc sections. The passage arc sections permit humor aqueous flow under the implant. The support arc sections make contact with the iris and provide the necessary support for the passage arc sections. Auricles extend from the support arc sections and are configured to hold the implant in place by engaging the eye at the iridocorneal angle. The implant may include an artificial lens, a limbal ring, and various means to anchor for the artificial lens.

Abstract: The present invention relates to the use of a compound having the formula (I) wherein: n represents an integer varying from 720 to 6 200, and i varies from 1 to n, Ri represents in particular OH, or a group of the formula (III) wherein k represents an integer varying from 1 to 17, and R?i represents a linear or branched alkyl chain comprising p carbon atoms, wherein p is an integer varying from 1 to 17, with the proviso that k+p is not greater than 28, and preferably not greater than 20, and wherein at least one Ri group represents a group of formula (III), for the preparation of a viscoelastic composition.

Abstract: A method is provided for increasing the outflow of fluid through Schlemm's canal that is useful for treatment of glaucoma. The implant is placed in Schlemm's canal by use of a flexible delivery instrument attached to the implant. The instrument and implant are positioned within the canal, the implant is released and the distal and proximal ends of the implant are connected to apply sufficient axial tensioning force on the inner wall of the canal to increase fluid permeability. In another embodiment a delivery instrument attached to the implant is positioned in the canal securing one of the distal or proximal ends of the implant within the canal. The implant provides sufficient axial tensioning force on the inner wall of the canal to increase fluid permeability of the inner wall of the canal. The other of the distal or proximal ends may be secured to maintain the tensioning force on the inner wall of the canal.

Abstract: A system for measuring the size of a capsular bag of an eye of a subject includes a size indicator and a sizing gauge. The size indicator is configured for insertion into a capsular bag and includes a peripheral portion and a pair of arms. The peripheral portion is configured to engage the capsular bag. Each of the arms has a proximal end and a distal end, the arms being joined to one another at the proximal ends. The peripheral portion is joined to the distal ends of the arms. The arms form an angle that depends on a size of the capsular bag into which the size indicator is placed. The sizing gauge has a body having a front surface, along with first and second features disposed along or behind the front surface. The features are configured to correspond to an angle that is within a predetermined range of angles of the arms of the size indicator when the size indicator is placed within a capsular bag.

Abstract: A visual prosthesis implant (1) is provided which comprises an SIMD-based processor array (6) adapted for receiving image signals from an image sensor (5) and outputting processed signals, and a bio-compatible electrode implant (7) receiving the processed signals and adapted for coupling to neurons. Using the SIMD-based processor array (6) provides high performance at small power dissipation and small chip area such that a fully implantable is visual prosthesis is achieved.

Abstract: Devices, methods and kits are described for reducing intraocular pressure. The devices include a support that is implantable within Schlemm's canal and that may restore or maintain at least partial patency of the canal without substantially interfering with transmural or transluminal fluid flow across the canal. The devices utilize the natural drainage process of the eye and may be implanted with minimal trauma to the eye. Kits may include a support and an introducer for implanting the support within Schlemm's canal. Methods may include implanting a support within Schlemm's canal, where the support is capable of restoring or maintaining at least partial patency of the canal without substantial interference with transmural or transluminal fluid flow across the canal.

Abstract: Implantation of an accommodating intraocular lens in an eye may require the accurate measurement of the size, circumference, or diameter of the capsular bag of the eye. After the natural crystalline lens has been surgically removed, a flexible ring may be temporarily or permanently inserted into the capsular bag for measuring the circumference of the capsular bag. The ring is generally compressible to fit through a surgical incision, then expands to fill the capsular bag along an equatorial region. The ring has a central component that changes shape as the ring is compressed. The shape change is generally correlated to the size of the capsular bag and may be measured visually or with a camera through the cornea, the measurement being generally independent of corneal magnification.

Abstract: Eye wall anchored fixtures each including at least one elongated anchor member for driven lengthwise insertion into an eye's eye wall in a transverse direction to its thickness for supporting an intraocular device in the eye's vitreous cavity. Fixtures are preferably anchored in circumferential incisions in a human adult eye's pars plana preferably 3.5 mm posterior to its corneal limbus, and perpendicular to a circumferential incision. The fixtures are either generally L-shaped with a single elongated anchor member designed for withdrawal from an eye wall or self-anchoring thereinto, or generally T-shaped with a pair of oppositely directed self-anchoring elongated anchor members for sealing a throughgoing incision. Intraocular devices can be designed for intraocular drug delivery, for acquiring intraocular physiological measurements, and the like.

Abstract: A prosthetic eye with an iris constructed of a photoresponsive, polymer based element. The photoresponsive element is responsive to light, so that the pupils constrict in the presence of light. The responsiveness of the pupils to light gives the prosthetic eye a more natural appearance.

Abstract: In accordance with exemplary embodiments of the present invention, an eye is presented with a therapeutic optical structure (e.g., corneal reshaping or by way of a contact lens) that focuses the peripheral image field in at least one meridian in front of the mid peripheral retina. In general, the therapeutic optical structure places the peripheral image field with reference to the retina in the direction and amplitude that growth is needed in order that the emerging myopia would be regulated. In accordance with exemplary embodiments of the present invention, an eye is presented with a therapeutic optical structure that further produces a central retinal image that is focused on the central retina in at least one meridian so as to not reshape the central cornea.

Abstract: An endoillumination system comprises a system controller and a light modulation apparatus responsive to the controller to alter at least one parameter associated with a input light beam to generate a modulated light beam. The endoillumination system further comprises an optical fiber for carrying the modulated light beam and a probe through which at least a portion of the optical fiber extends. The probe is sized for insertion into an eye.

Abstract: The present invention relates to hydrophilic dicationic siloxane prepolymers with one polymerizable vinyl moiety instead of two polymerizable vinyl moieties, resulting in contact lenses and/or biomedical devices with reduced cross-link density and modulus without detracting from other properties.

Abstract: An artificial sphincter system having: (1) a hollow object, which has the ability of contraction and expansion; (2) a shape memory alloy (SMA), which is connected with the hollow object, changes its shape to imitate the motion of human muscle by applying different electric current; (3) an electric power to provide different amounts of electric current to the shape memory alloy and let it contract or expand to control the motion of the hollow object to imitate the motion of human muscle; and (4) a photo resistor added between the electric power and the shape memory alloy, which senses the brightness of surrounding light and controls A/D (analog-to-digital) values of the electric power to cause different conditions of contraction and expansion of each part of the shape memory alloy.

Abstract: An implantable system for restoring accommodation capacity includes at least one ring configured to be implanted in a ciliary sulcus and a capacitor with a first capacitor plate and a second capacitor plate. The first capacitor plate is arranged on an implantable ring and the second capacitor plate is connected to a capsular bag.

Abstract: This invention is directed towards ophthalmic lenses used to assist during vitreoretinal surgery. More specifically, it is directed towards ophthalmic lenses that are constructed to generate a high-resolution image of the retinal surface during surgery while maintaining a minimal mechanical envelop all while using materials and assembly methods compatible with autoclave sterilization techniques.

Abstract: A scleral prosthesis includes a prosthesis body having first and second side surfaces and a cavity extending through the prosthesis body from the first side surface to the second side surface. The scleral prosthesis also includes a crossbar configured to be inserted into the cavity, where the crossbar is wider than the prosthesis body. The cavity could define a narrower central opening and wider end openings, and the crossbar could have a narrower central portion and wider end portions. Also, the prosthesis body could include multiple cavities, and the scleral prosthesis could include multiple crossbars configured to be inserted into the multiple cavities. Each of the cavities could be located proximate to an end of the prosthesis body. The crossbar could be substantially straight with a cylindrical cross section.

Abstract: One example scleral prosthesis includes a first free end and a second free end, each wider than a middle portion of the scleral prosthesis. Multiple first portions form the first end of the scleral prosthesis. The first portions are separated along at least half of a length of the scleral prosthesis. Multiple second portions may form the second end of the scleral prosthesis, and the second portions may be separated along less than a quarter of the length of the scleral prosthesis. An implantation device can be used to facilitate implantation of a scleral prosthesis. The implantation device includes a first end portion configured to be inserted into a scleral tunnel of an eye. The implantation device also includes a second end portion configured to receive the scleral prosthesis. A rod with a tapered and rounded end can be partially inserted into the first end portion of the implantation device.

Abstract: The object of providing a device for reversibly attaching an implant to an eye, with which the implant can be attached in a simple way to the eye and can if necessary be detached or removed from the eye, is achieved according to the present invention by means of a device for attaching an implant by means of a pin that comprises a substantially elongated shaft, wherein the implant includes an implant film for contacting living tissue or nerves in the visual system of the eye and the implant film has an opening through which the shaft of the pin can be at least partially inserted, characterised in that the device includes a holding element that can be arranged on the shaft of the pin so that the holding element engages on the shaft of the pin and is fixed in an attachment position to the pin.

Abstract: A human body implant structure includes: a support anchor which is embedded into a bone body; a support base which is placed on and fixed to an upper portion of the support anchor; and a lost-part compensation part which is mounted on an upper portion of the support base, wherein the support anchor and the support base are configured to be detachably fitted to each other by way of the taper fitting structure where the support anchor and the support base are brought into close contact with each other, and a stepped portion which is formed of an upper surface of the support anchor is formed on a boundary between a female threaded hole which is vertically formed in the support base and a vertical hole formed in the upper surface of the support anchor.

Abstract: A novel system for coloring tissues of the human eye, especially methods of coloring the iris, includes drying the tissue surface, applying colorant to the dried surface, and then drying the applied colorant. The system avoids tattooing, implanting, and corneal modification. Permanent results may be obtained. Colorants may be coatings or stains.

Abstract: A capsular bag for the artificial vitreous body is made up of a material selected from the group consisting of polysiloxane, polyurethane styrene triblock copolymer thermoplastic elastomers, hydroxyethyl methacrylate, polyvinyl alcohol, poly (lactide-co-glycolide, and hyaluronic acid ester. A method for manufacturing the capsular bag for the artificial vitreous body is performed by dip-molding, effectively improving the smoothness of the inner surface of the capsule. An eye die is dipped into a gel solution until the surface adsorbs the gel, and then lifted, repeating 3-6 times. The dipped eye is hardened into shape. A shaped spherical outer capsule is peeled out of the eye die. The capsular bag for the artificial vitreous body has high biocompatibility and excellent flexibility.

Abstract: In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.

Abstract: An ocular implant is provided. In some embodiments, the ocular implant includes a body that is curved about a longitudinal central axis and a distal body portion that defines a longitudinal channel including a channel opening. The implant is sized and configured such that the ocular implant assumes an orientation in which the channel opening is adjacent a major side of Schlemm's canal when the ocular implant is disposed in Schlemm's canal. Methods for delivering ocular implants into Schlemm's canal are also provided. Some methods include covering openings in the ocular implant, advancing the implant into Schlemm's canal while at least some of the openings are covered, and uncovering the openings while the distal portion of the implant is disposed in Schlemm's canal.

Abstract: A fiber matrix is provided for maintaining space in soft tissue, for example for use in procedures for assisting drainage of aqueous humor from an eye to treat glaucoma. The fiber matrix comprises a plurality of crossing fibers forming a mesh with a plurality of void spaces. The fibers and void spaces are sized and arranged so as to permit passage of fluid through the fiber matrix and to inhibit formation of scar tissue through the fiber matrix. The fibers may comprise a polymeric material, and the fiber matrix may be manufactured by electrospinning. The fibers may comprise a biostable and/or a biodegradable material. In one method of using a fiber matrix, the fiber matrix is positioned under a scleral flap, with at least part of the fiber matrix under the scleral flap.

Abstract: Prosthetic devices, methods and systems are disclosed. Eye position and/or neural activity of a primate are recorded and combined. The combination signal is compared with a predetermined signal. The result of the comparison step is used to actuate the prosthetic device.

Abstract: An implantable kinetic power generator has an oscillating weight that is physically coupled to a first gear. A second gear with a rotor at its center of rotation is coupled to the first gear. A generating coil is located in close proximity to the rotor. An energy storage unit is electrically coupled to the coil. A shell suitable for implantation in the eye encloses these components. When the rotor rotates, energy generated by the coil is stored in the energy storage unit.

Abstract: Infinite gradient refractive index ophthalmic devices and methods of making same. The method involves diffusing a monomer which polymerizes to a lower or higher corresponding opposite refractive index polymer into a lower or higher index polymer structure and polymerizing same to create the gradient structure. The resulting polymeric structure is used to manufacture ophthalmic devices, e.g., intraocular lenses.

Abstract: Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.

Abstract: The present invention relates to amphiphilic block copolymers comprising at least one block of hydrophilic units and at least one block of hydrophobic units, wherein at least one hydrophobic block contains siloxane units. The present invention may be particularly useful as a tissue adhesive or as a coating for an intraocular lens (IOL). As an IOL coating, copolymers according to the invention may be used, for example, to promote tissue adhesion for the prevention of posterior capsule opacification.

Abstract: Opthalmic devices, particularity intraocular lenses (IOL), with improved contrast sensitivity and methods of making same. In one aspect, blue light blocking chromophores (BLBC) are diffused into, e.g. an IOL lens body to create a BLBC gradient in the lens. Orange dyes are preferred BLBCs.

Abstract: A unitary scleral buckling element for treating a retinal defect within an eye of a subject is disclosed. The scleral buckling element has a band portion for encircling the eye and an enlarged portion formed along the length of the band portion, which is configured to overlie a retinal defect. In one aspect, the width of the enlarged portion is greater than the width of the band portion of the scleral buckling element.

Abstract: The subject of the invention is a covering filtering material for protecting eyes which are healthy, pseudo-aphakic (operated for cataracts) and/or having retinal degeneration under shortwave lengths, which results from the application of a filter with yellow pigmentation on any covering, coating or screening material with the purpose of protecting the eyes from the shortwave lengths of visible spectrum from 500 to 380 nm which cause retinal degeneration. By way of example, this element may be applied in materials intended for manufacturing awnings, parasols or insulating materials or protection screens of any type.

Abstract: An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The invention also provides a method of treating glaucoma including the steps of supporting tissue forming Schlemm's canal in an eye with an implant extending at least partially in the canal along an axial length within the canal; and contacting with the implant less than 50% of the tissue forming the canal along the axial length.

Abstract: Presbyopia and other eye disorders are treated by implanting within a plurality of elongated pockets formed in the tissue of the sclera of the eye transverse to a meridian of the eye, a prosthesis adapted for contact with the sclera of an eyeball, and comprising a body having a first end and a second end wherein the body has (i) a planform adapted to expand the contacted sclera to increase the effective working distance of the ciliary muscle of the eyeball, and (ii) means for stabilizing the prosthesis within the surgically formed pocket within the sclera of the eyeball.

Abstract: The present invention refers to an implantable optical system comprising a central optical part and an annular anchoring part, where said annular part comprises animals cells, including human cells, that encourage the integration of the implant into the ocular tissue of the patient, as well as a system for dosing chemical compounds directed at a particular function, creating a stabilising microenvironment for the presence of the implant in the tissue. A method for obtaining said system by polymerisation and its applications in various types of ocular disorders is also described.

Abstract: It is an object of the present invention to provide an ocular lens superior in the wettability of the surface thereof, hydrating properties, oxygen permeability, flexibility, elasticity, transparency and shape recoverability though it has a composition using a silicone-containing monomer. The present invention relates to a highly oxygen-permeable hydrated ocular lens obtained by saponifying a copolymer prepared from a specific both-terminal (meth)acryl polydimethylsiloxane, a vinyl carboxylate, a (meth)acrylamide type monomer, a vinyl type crosslinking agent, one or both of a (meth)acrylate having a tertiary structure and a (meth)acrylate having a cyclic structure as (meth)acrylates each having a bulky structure at its side chain and a monomer copolymerizable with these compounds.

Abstract: Presbyopia is treated by implanting within a plurality of elongated pockets formed in the tissue of the sclera of the eye transverse to a meridian of the eye, a prosthesis having an elongated body having a first surface and a second surface opposite the first surface to contact the base and flap of the scleral pocket. The first and second surfaces are spaced apart a distance so that the implanted prosthesis exerts an outward force on the flap of the scleral pocket which results in an outward traction on at least the anterior margin of the scleral pocket. The combined effect of the implanted prostheses is to exert a radially outward traction on the sclera in the region overlying the ciliary body which expands the sclera in the affected region together with the underlying ciliary body. The expansion of the ciliary body restores the effective working distance of the ciliary muscle in the presbyopic eye and thereby increases the amplitude of accommodation.

Abstract: In one aspect, the present invention provides a method of designing an intraocular lens (IOL) to address variations of at least one ocular parameter in a population of patient eyes. The method can include establishing at least one eye model in which the ocular parameter can be varied over a range exhibited by the population. The eye model can be employed to evaluate a plurality of IOL designs in correcting visual acuity for eyes in the patient population. An IOL design that provides a best fit for visual performance over at least a portion of the parameter range can then be selected.

Abstract: An intraocular implant including a sealed capsule adapted for intraocular placement upstream of a retina, an electronic display located within the sealed capsule, electronic circuitry located within the sealed capsule for operating the electronic display, the electronic circuitry and the electronic display operative to selectably provide multiple display options, the multiple display options including allowing at least some light from the outside to pass through the electronic display and focusing optics located within the sealed capsule.

Abstract: A method and intrastroma insert are adapted to modify eye color. The insertion of opaque material into the stromal space is a means of changing the color and/or design of the stroma and, apparently, the iris. Biocompatible inserts include a slurry of biocompatible material, a fabric including opacified material, and a thin, permeable film material incorporating some opaque materials that may also alter the shape of the cornea to improve aberrational shape.

Abstract: Intraocular lenses comprised of an acrylic-silicone hybrid polymer are disclosed. The intraocular lenses described herein are suitable for insertion through incisions of 2 mm or less.

Abstract: The present invention relates to polymeric compositions useful in the manufacture of biocompatible medical devices. More particularly, the present invention relates to certain cationic monomers capable of polymerization to form polymeric compositions having desirable physical characteristics useful in the manufacture of ophthalmic devices. Such properties include the ability to extract the polymerized medical devices with water. This avoids the use of organic solvents as is typical in the art. The polymer compositions comprise polymerized silicon-containing monomers end-capped with polymerizable cationic hydrophilic groups.

Abstract: A prosthetic device and method to restore extraocular muscle function. The device includes a housing; a biasing component disposed in the housing; a proximal connector operatively connected to a proximal end of the biasing component; and a distal connector operatively connected to a distal end of the biasing component, wherein the proximal connector is configured for being secured with respect to an orbital bone and the distal connector adapted to be secured to the paralyzed or absent muscle stump, e.g. on the globe, or to the eyelid.

Abstract: The invention relates to a novel apparatus for the treatment of ocular disease, particularly glaucoma. The apparatus consists of a locating device to locate Schlemm's Canal within the anterior portion of the eye and a surgical tool to access the canal for treatment. The apparatus allows for guided, minimally invasive surgical access to Schlemm's Canal to enable surgical procedures to be performed on the canal and trabecular meshwork to reduce intraocular pressure. The apparatus may also deliver devices or substances to Schlemm's Canal in the treatment of glaucoma.

Abstract: A vision prosthesis includes an optical element having a surface that is shaped to be positioned near a cornea of an eye, and a magnetic element embedded in the optical element.

Abstract: An ocular implant adapted to reside at least partially in a portion of Schlemm's canal of an eye. In some embodiments the implant has a body extending in a curved volume whose longitudinal axis forms an arc of a circle, and a plurality of open areas and strut areas formed in the body, the open areas extending over more than 50% of a surface defining the curved volume, the strut areas surrounding the open areas, the body having a diameter of between 0.005 inches and 0.04 inches. The invention also provides a method of treating glaucoma including the steps of supporting tissue forming Schlemm's canal in an eye with an implant extending at least partially in the canal along an axial length within the canal; and contacting with the implant less than 50% of the tissue forming the canal along the axial length.

Abstract: A system includes an intraocular lens configured to replace a natural crystalline lens of an eye. The system also includes one or more scleral prostheses configured to be inserted into scleral tissue of the eye. The one or more scleral prostheses are configured to modify a structure of the eye to improve an accommodative ability of the eye with the intraocular lens. The intraocular lens could represent an accommodating intraocular lens, and the one or more scleral prostheses could be configured to increase an amount of accommodation achievable using the accommodating intraocular lens. The intraocular lens could also represent a non-accommodating intraocular lens, and the one or more scleral prostheses could be configured to provide an amount of accommodation achievable using the non-accommodating intraocular lens.

Abstract: A reading enhancement device for preventing and/or treating presbyopia of the eye. The enhancement device is sutured to an outer wall of the sclera for buckling and compressing a portion of the sclera and the ciliary body inwardly and perpendicular to the plane of the sclera and exerting a posterior compression force toward the vitreous humor in the rear of the eye. The enhancement device includes a compression body with a front of the body having semi-circular convex surface. The convex surface is used for engaging, buckling and compressing both a portion of the sclera and the ciliary body of the eye. The compression body also includes an enlarged, rounded first and second end portions and an elongated center portion with the convex surface formed thereon. Also, the compression body includes a rear having an outwardly extending rib portion with a pair of grooves at opposite ends of the rib portion.